Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13

Nature Immunology

Volumn 9, Issue 1, 2008, Pages 73-80

  Bansal, Geetanjali ^a   Xie, Zhihui ^a   Rao, Sudhir ^b,c,d   Nocka, Karl H ^b,c   Druey, Kirk M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UCB PHARMA   (Belgium)

^c MERCK RESEARCH LABORATORIES   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; RGS PROTEIN; RGS13 PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANAPHYLAXIS; ANIMALS; CELL DEGRANULATION; CELLS, CULTURED; ENZYME ACTIVATION; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, KNOCKOUT; RECEPTORS, IGE; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 37349103993     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1533     Document Type: Article

References (50)

1. Metz, M. & Maurer, M. Mast cells-key effector cells in immune responses. Trends Immunol. 28, 234-241 (2007).
2. Ra, C., Jouvin, M.H. & Kinet, J.P. Complete structure of the mouse mast cell receptor for IgE (Fc6RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J. Biol. Chem. 264, 15323-15327 (1989).
3. Fukao, T. et al. Selective loss of gastrointestinal mast cells and impaired immunity in P13K-deficient mice. Nat Immunol. 3, 295-304 (2002).
4. Ali, K. et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431, 1007-1011 (2004).
5. Gilfillan, A.M. & Tkaczyk, C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6, 218-230 (2006).
6. Nguyen, M. et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J. Immunol. 169, 4586-4593 (2002).
7. Zhong, H. et al. Activation of murine lung mast cells by the adenosine A3 receptor. J. Immunol. 171, 338-345 (2003).
8. Olivera, A. & Rivera, J. Sphingolipids and the balancing of immune cell function: Lessons from the mast cell. J. Immunol. 174, 1153-1158 (2005).
9. Jolly, P.S. et al. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp Med. 199, 959-970 (2004).
10. Gilman, A.G. G proteins: Transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649 (1987).
11. Willars, G.B. Mammalian RGS proteins: Multifunctional regulators of cellular signalling. Semin. Cell Dev. Biol. 17, 363-376 (2006).
12. Druey, K.M. Bridging with GAPs: Receptor communication through RGS proteins. Sci. STKE[online] 104, RE14 (2001)(doi:10.1126/ stke.2001.1104.re1114).
13. Hernandez-Hansen, V. et al. Increased expression of genes linked to FcsRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells. J. Immunol. 175, 7880-7888 (2005).
14. Taymans, J.M., Leysen, J.E. & Langlois, X. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem. 84, 1118-1127 (2003).
15. Laffargue, M. et al. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16, 441-451 (2002).
16. Heximer, S.P., Watson, N., Linder, M.E., Blumer, K.J. & Hepler, J.R. RGS2/G058 is a selective inhibitor of Gqα function. Proc. Natl. Acad. Sci. USA 94, 14389-14393 (1997).
17. Fukao, T., Terauchi, Y., Kadowaki, T. & Koyasu, S. Role of phosphoinositide 3-kinase signaling in mast cells; new insights from knockout mouse studies. J. Mol. Med. 81, 524-535 (2003).
18. Yu, M., Lowell, C.A., Neel, B.G. & Gu, H. Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcεRI. J. Immunol. 176, 2421-2429 (2006).
19. Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 (2001).
20. Yamanashi, Y. et al. Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 89, 1118-1122 (1992).
21. Cuevas, B.D. et al. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276, 27455-27461 (2001).
22. Zhu, M., Rhee, I., Liu, Y. & Zhang, W. Negative regulation of FcεRI-mediated signaling and mast cell function by the adaptor protein LAX. J. Biol. Chem. 281, 18408-18413 (2006).
23. Andrade, M.V., Hiragun, T. & Beaven, M.A. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mastrells. J. Immunol. 172, 7254-7262 (2004).
24. Zhang, J., Berenstein, E.H., Evans, R.L. & Siraganian, R.P. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J. Exp. Med. 184, 71-79 (1996).
25. Reischl, I.G., Coward, W.R. & Church, M.K. Molecular consequences of human mast cell activation following immunoglobulin E-high-affinity immunoglobulin E receptor (IgE-FcεRI) interaction. Biochem. Pharmacol. 58, 1841-1850 (1999).
26. Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. & Foukas, L.C. Signalling by P13K isoforms: Insights from gene-targeted mice. Trends Biochem. Sci. 30, 194-204 (2005).
27. Nechushtan, H., Leitges, M., Cohen, C., Kay, G. & Razin, E. Inhibition at degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 95, 1752-1757 (2000).
28. Leitges, M. et al. Protein kinase C-δ is a negative regulator of antigen-induced mast cell degranulation. Mol. Cell. Biol. 22 3970-3980 (2002).
29. Zhang, C., Hirasawa, N. & Beaven, M.A. Antigen activation of mitogen-activated protein kinase in mast cells through protein kinase C-dependent and independent pathways. J. Immunol. 158, 4968-4975 (1997).
30. Olenchock, B.A. et al. Impaired degranulation but enhanced cytokine production after FcεRI stimulation of diacylglycerol kinase ζ-deficient mast cells. J. Exp. Med. 203, 1471-1480 (2006).
31. Kitaura, J. et al. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192, 729-740 (2000).
32. 2+/calmodulin directly interacts with the pleckstrin homology domain of AKT1. J. Biol. Chem. 282 25131-25140 (2007).
33. 2+/Calmodulin reverses phosphatidylinositol 3,4, 5-trisphosphate-dependent inhibition of regulators of G protein-signaling GTPase-activating protein activity. J. Biol. Chem. 275, 18962-18968 (2000).
34. Hollinger, S. & Hepler, J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54, 527-559 (2002).
35. Lu-Kuo, J.M., Fruman, D.A., Joyal, D.M., Cantley, L.C. & Katz, H.R. Impaired kit- but not FcεRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85α gene products. J. Biol. Chem. 275, 6022-6029 (2000).
36. Bernstein, L.S., Grillo, A.A., Loranger, S.S. & Linder, M.E. RGS4 binds to membranes through an amphipathic α-helix. J. Biol. Chem. 275, 18520-18526 (2000).
37. iα1: Stabilization of the transition state for GTP hydrolysis. Cell 89, 251-261 (1997).
38. Heximer, S.P. & Blumer, K.J. RGS proteins: Swiss army knives in seven-transmembrane domain receptor signaling networks. Sci. STKE [online] 370, pe2 (2007) (doi:10.1126/stke.3702007pe3702002).
39. 2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. Nat. Cell Biol. 7, 405-411 (2005).
40. Liu, W. et al. Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proc. Natl. Acad. Sci. USA 103, 18338-18343 (2006).
41. Hague, C. et al. Selective inhibition of α1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J. Biol. Chem. 280, 27289-27295 (2005).
42. Han, S.B. et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 22, 343-354 (2005).
43. Shi, G.X., Harrison, K., Wilson, G.L., Moratz, C. & Kehrl, J.H. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169, 2507-2515 (2002).
44. Estes, J.D. et al. Follicular dendritic cell regulation of CXCR4-mediated germinal center CD4 T cell migration. J. Immunol. 173, 6169-6178 (2004).
45. Beadling, C., Druey, K.M., Richter, G., Kehrl, J.H. & Smith, K.A. Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes. J. Immunol. 162, 2677-2682 (1999).
46. Youssef, L.A. et al. Histamine release from the basophils of control and asthmatic subjects and a comparison of gene expression between "releaser" and "nonreleaser" basophils. J. Immunol. 178, 4584-4594 (2007).
47. Saitoh, S. et al. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12, 525-535 (2000).
48. Dombrowicz, D., Flamand, V., Brigman, K.K., Koller, B.H. & Kinet, J.P. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell 75, 969-976 (1993).
49. Manetz, T.S. et al. Vav1 regulates phospholipase cγ activation and calcium responses in mast cells. Mol. Cell. Biol. 21, 3763-3774 (2001).
50. Nagahara, H. et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449-1452 (1998).